Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Göran Bodemar"'
Publikováno v:
Acta Medica Scandinavica. 208:27-31
Cimetidine has been administered during 7 days to 28 patients with different degrees of renal failure. Thirteen of these patients had a further week's treatment at least one month later. The daily dose of cimetidine was reduced in relation to pretria
Autor:
Ulrik Mathiesen, Lars Thorelius, Göran Bodemar, Lennart Franzén, Marika Holmqvist, Stergios Kechagias, Mattias Ekstedt
Publikováno v:
Hepatology. 44:865-873
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of elevated liver enzymes in patients of developed countries. We determined the long-term clinical and histological courses of such patients. In a cohort study, 129 consecutively enrol
Publikováno v:
Scandinavian Journal of Gastroenterology. 39:454-458
Background: Inflammatory bowel disease (IBD)-associated anaemia usually responds to intravenous iron. If not, additive treatment with erythropoietin has been proposed. The objective of the present retrospective study was to evaluate the effectiveness
Autor:
U Foberg, M. Resjo, L. Jacobsson, UL Mathiesen, Göran Bodemar, Aril Frydén, Lennart Franzén, H Åselius
Publikováno v:
Digestive and Liver Disease. 34:516-522
Aims. To investigate whether hyperechogenicity of liver can reliably be interpreted as liver steatosis and if any concomitant or isolated fibrosis can be disclosed. Patients and methods. A series of 165 patients with no signs or symptoms of liver dis
Publikováno v:
Scandinavian Journal of Gastroenterology. 37:68-73
This study describes how surgery for Crohn colitis developed between 1970 and 1997, towards the end of which period limited resection and medical maintenance treatment was introduced.A cohort of 211 patients with Crohn colitis (115 population-based),
Publikováno v:
Scandinavian Journal of Gastroenterology. 36:833-842
It is unclear how the quality and quantity of abdominal symptoms and anorectal function differ between irritable bowel syndrome (IBS) patients and healthy controls, and whether different anorectal function in patients is associated with abdominal sym
Publikováno v:
Alimentary Pharmacology & Therapeutics. 14:23-34
Background: Irritable bowel syndrome is a common gastrointestinal disorder characterized by abdominal pain and discomfort and altered bowel habit. Antagonism at the 5-HT3 receptor may be of benefit in the treatment of irritable bowel syndrome. Aims:
Publikováno v:
Acta Medica Scandinavica. 205:87-89
Serum creatinine, endogenous creatinine clearance, (51Cr)EDTA plasma clearance and the concentration of beta2-microglobulin in serum and urine were determined in 19 patients before and during treatment with cimetidine for peptic ulcer disease. The me
Autor:
Göran Bodemar, Gudmundur Ragnarsson
Publikováno v:
European Journal of Gastroenterology & Hepatology. 10:415-422
To study the intensity and variation of pain and its temporal relation to eating and defaecation. Furthermore, what irritable bowel (IBS) patients mean by constipation and diarrhea and how bowel symptoms vary.Prospective daily symptom recording over
Publikováno v:
Scandinavian Journal of Gastroenterology. 33:224-230